Tendinosis
disease diseaseOn this page
Summary
Tendinosis (MONDO:0100011) is a disease and 13 clinical trials. A subtype of disease of the tendon — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 13
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | tendinosis |
| Mondo ID | MONDO:0100011 |
| SNOMED CT | 724152009 |
| UMLS | C1568363 |
| MedGen | 293673 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of disease of the tendon. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › disease of the tendon › tendinosis
Related subtypes (2): tendinitis, tendon sheath disorder
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 13.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 10 |
| PHASE3 | 1 |
| PHASE2 | 1 |
| PHASE1/PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT00196573 | PHASE3 | UNKNOWN | Subacromial Decompression Versus Subacromial Bursectomy for Patients With Rotator Cuff Tendinosis |
| NCT01600326 | PHASE2 | COMPLETED | A Prospective Comparison of Ultrasound-Guided Percutaneous Platelet-Rich Plasma Injection |
| NCT02330146 | PHASE1/PHASE2 | TERMINATED | Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis |
| NCT05352139 | Not specified | ENROLLING_BY_INVITATION | Treatment of Tendinosis Using the TenJet Hydroresection System |
| NCT07540806 | Not specified | NOT_YET_RECRUITING | Ultrasound-Guided Percutaneous Needle Tenotomy (PNT) vs Percutaneous Ultrasonic Needle Tenotomy (PUT) for Gluteal Tendinosis |
| NCT02466308 | Not specified | COMPLETED | Long Duration Therapeutic Ultrasound for Tendon Healing |
| NCT02655042 | Not specified | WITHDRAWN | Long-Term Follow-up of the Safety and Efficacy of RCT-01 in Men and Women With Unilateral, Chronic Achilles Tendinosis |
| NCT03090672 | Not specified | UNKNOWN | Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease |
| NCT03504111 | Not specified | UNKNOWN | PRINT Trial (Platelet Rich Injection vs Needle Tenotomy) |
| NCT03987256 | Not specified | UNKNOWN | ECRB Tendinopathy: Needling ± PRP After Failure of Rehabilitation |
| NCT05030402 | Not specified | COMPLETED | Efficacy of Maitland Mobilization in Shoulder Pathology |
| NCT05132959 | Not specified | COMPLETED | The Morphometric Parameters of Shoulder and Supraspinatus Tendinosis |
| NCT06571695 | Not specified | COMPLETED | Restoring the Anatomic Tension Relationship of the Long Head of the Biceps During Tenodesis |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.